Galactosaminoglycans from normal myometrium and leiomyoma by Berto, A.g.a. et al.
633
Braz J Med Biol Res 34(5) 2001
xxxxxxx
Galactosaminoglycans from normal
myometrium and leiomyoma
Departamento de Bioquímica, Escola Paulista de Medicina,
Universidade Federal de São Paulo, São Paulo, SP, Brasil
A.G.A. Berto, S.M. Oba,
Y.M. Michelacci
and L.O. Sampaio
Abstract
In many tumors, the amount of chondroitin sulfate in the extracellular
matrix has been shown to be elevated when compared to the corre-
sponding normal tissue. Nevertheless, the degree of chondroitin sul-
fate increase varies widely. In order to investigate a possible correla-
tion between the amount of chondroitin sulfate and tumor size, several
individual specimens of human leiomyoma, a benign uterine tumor,
were analyzed. The glycosaminoglycans from eight tumors were
extracted and compared with those from the respective adjacent
normal myometrium. The main glycosaminoglycan found in normal
myometrium was dermatan sulfate, with small amounts of chondroitin
sulfate and heparan sulfate. In leiomyoma, both dermatan sulfate and
chondroitin sulfate were detected and the total amounts of the two
galactosaminoglycans was increased in all tumors when compared to
normal tissue. In contrast, the heparan sulfate concentration decreased
in the tumor. To assess the disaccharide composition of galactosami-
noglycans, these compounds were incubated with bacterial chondroi-
tinases AC and ABC. The amounts of L-iduronic acid-containing
disaccharides remained constant, whereas the concentration of D-
glucuronic acid-containing disaccharides increased from 2 to 10 times
in the tumor, indicating that D-glucuronic acid-containing disaccha-
rides are responsible for the elevation in galactosaminoglycan concen-
tration. This increase is positively correlated with tumor size.
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Glycosaminoglycans (GAGs) are hetero-
polysaccharide chains made up of disaccha-
ride-repeating units, in which one sugar is a
hexosamine and the other is either a neutral
sugar or a uronic acid. The GAG chains are
sulfated to different extents and at different
positions. The carboxyl groups of the uronic
acids and the sulfate residues give the GAGs
a polyanionic nature. With the exception of
hyaluronic acid, which is not sulfated and
occurs as free chains in tissues, every GAG
is covalently linked to a protein, forming
proteoglycans.
Proteoglycans are important components
of cell surface and extracellular matrices and
individual proteoglycans interact specifical-
ly with other matrix components, such as
collagen, laminin, and fibronectin, as well as
with growth factors and cytokines (1-3).
These interactions may affect cell growth,
migration, adhesiveness, and differentiation,
and many of these functions seem to be
dependent on the GAG side chains (4).
Sampaio and Dietrich (5) have first shown
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that the type and quantity of GAGs in mature
normal tissues differ from those found dur-
ing embryonic development and in tumors
(6). Chondroitin sulfate and dermatan sul-
fate, also referred to as galactosaminoglycans
because they contain N-acetylgalactosamine
as their hexosamine, are the most common
GAGs in the extracellular matrix proteogly-
cans (7). The uronic acid in chondroitin
sulfate is always D-glucuronic acid, whereas
dermatan sulfate is a hybrid polymer, con-
taining both L-iduronic acid and D-glucu-
ronic acid residues.
Chondroitin sulfate was greatly increased
in transformed cells in culture compared to
normal cells (8). The amount of extracellular
chondroitin sulfate in many tumors is also
high when compared to the normal tissue of
origin (6,9), but the magnitude of this in-
crease varies widely, depending on the size
and type of tumor (10).
The first study on the composition of
sulfated GAGs in the uterus is from the
1960s (11), when it was shown that normal
myometrium contains heparan sulfate, chon-
droitin sulfate, and dermatan sulfate. The
proportions among these three GAGs did not
vary significantly in pre- and postmenopause
or in pre- and postgestation uterus. Although
variations in the concentration of GAGs have
been found, it was not possible to establish
correlations between these variations and
any of the analyzed parameters, such as pa-
tient age. The only correlations established
were a significant decrease of uterine GAG
during pregnancy (12,13) and an increase in
chondroitin sulfate in leiomyoma, a benign
tumor of the myometrium (6), and in leio-
myosarcoma, a malignant tumor of the same
tissue (14). Again, the magnitude of this
increase varied from 2 to 20 times (6).
In order to determine if this variation in
chondroitin sulfate concentration is a func-
tion of tumor class or size, or is due only to
biological variability, several tumors of the
same type were individually analyzed. The
aim of the present investigation was to per-
form a more systematic study on the GAG
composition of leiomyoma, in order to es-
tablish a possible correlation between GAGs
and some parameters of neoplastic develop-
ment in human myometrium.
Human leiomyomas were obtained short-
ly after surgical excision. Tumoral and adja-
cent normal myometrium were dissected and
stored at -20oC until use. The frozen tissues
were weighed and ground in 10 volumes of
acetone. After standing overnight at room
temperature, the tissues were collected by
centrifugation and dried. About 0.45 g of the
acetone powder thus obtained from normal
myometrium and leiomyoma was incubated
overnight with papain (2 mg/ml in 0.06 M
phosphate-cysteine buffer, pH 6.5, contain-
ing 20 mM EDTA) at 60oC. Afterwards,
debris was removed by centrifugation (5,000
g) for 15 min. Trichloroacetic acid and NaCl
were added to the supernatant up to 10% and
1-M final concentrations, respectively. The
mixture was left to stand for 10 min at 4oC
and the precipitate formed was removed by
centrifugation at 4,000 g for 10 min at 4oC.
The GAGs were precipitated from the super-
natant by the slow addition of 2 volumes of
ethanol with shaking. After 18 h at -20oC the
precipitate was collected by centrifugation,
vacuum dried, resuspended in 0.5 ml of a
solution containing deoxyribonuclease I (1
mg/ml) and 50 mM sodium acetate buffer,
pH 6.0, and incubated at 30oC for 12 h. The
GAGs were analyzed by a combination of
agarose gel electrophoresis and degradation
with specific bacterial mucopolysacchari-
dases.
Comparative results for leiomyoma and
normal adjacent myometrium obtained from
eight patients revealed important structural
alterations of GAG content. Figure 1A shows
the electrophoretic migration of GAGs
extracted from one of these samples. The
difference in GAG composition is evident.
In normal myometrium, the main sulfated
GAG is dermatan sulfate with small amounts
of chondroitin sulfate and heparan sulfate,
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while in leiomyoma the main GAGs are
chondroitin sulfate and dermatan sulfate. As
chondroitin sulfate and dermatan sulfate
migrate very close to each other, it was diffi-
cult to determine their individual concentra-
tions. For this reason, the galactosaminogly-
cans (chondroitin sulfate and dermatan sul-
fate) were quantified together by densitom-
etry of the agarose gel slabs. The concentra-
tion of galactosaminoglycans (expressed as
mg per g dry tissue) increased in all samples
of tumor tissue as compared to the respective
adjacent normal myometrium (Figure 1B).
In contrast, the heparan sulfate contents de-
creased in all cases (Figure 1B). The mean
values and standard errors are also shown.
To investigate if this increase was due to
both chondroitin sulfate and dermatan sul-
fate, the disaccharide units that compose
these polymers were analyzed. The GAGs
were incubated with chondroitinase AC (from
Flavobacterium heparinum) (15) and chon-
droitinase ABC (from Proteus vulgaris) (16).
The degradation products formed were ana-
lyzed by paper chromatography stained with
alkaline silver nitrate (17) and quantified by
densitometry. Both dermatan sulfate and
chondroitin sulfate are hybrid polymers.
Chondroitin sulfate is composed of 4- and 6-
sulfated disaccharide units, all of them con-
taining D-glucuronic acid (18). Dermatan
sulfate, on the other hand, contains both D-
glucuronic and L-iduronic acid residues (19).
The combined action of chondroitinases AC
and ABC permits to assess the amounts of
these disaccharide units in the polymers.
Chondroitinase AC degrades chondroitin
sulfate and the D-glucuronic acid-contain-
ing regions of dermatan sulfate. L-Iduronic
acid-containing regions are not substrates
for this enzyme but are degraded by chon-
droitinase ABC. Figure 2A shows that both
4-sulfated and 6-sulfated disaccharides were
formed from normal and tumoral GAGs by
chondroitinase AC (D-glucuronic acid) but
more 4-sulfated disaccharides were produced
by chondroitinase ABC, indicating the pres-
ence of L-iduronic acid. Nevertheless, the L-
iduronic acid contents of tumors were unal-
tered when compared to the adjacent normal
tissue, in contrast to the D-glucuronic acid
contents that increased in all cases (Figure
2A) with magnitudes ranging from 1.7 to 11
times. Furthermore, Figure 2B shows that
the amounts of D-glucuronic acid-contain-
ing disaccharides were positively correlated
Figure 1. Sulfated glycosami-
noglycans (GAGs) from normal
human myometrium (N) and leio-
myoma (T). A, Agarose gel elec-
trophoresis of GAGs extracted
from leiomyoma and normal ad-
jacent myometrium from patient
1: about 5 µl of the GAGs
extracted as described in the
text was submitted to agarose
gel electrophoresis in 0.05 M
1,3-diaminopropane acetate buf-
fer, pH 9.0, as previously de-
scribed (6). Sd: mixture of stan-
dard GAGs; CS: chondroitin sul-
fate; DS: dermatan sulfate; HS:
heparan sulfate. B, Amounts of
CS plus DS (CS + DS) and HS
extracted from eight tumors and
from their respective adjacent
normal myometrium. The GAGs
were quantified by densitometry
(525 nm) of the agarose gel
slabs and the figure shows the
individual results obtained. Data
are reported as the mean ±
SEM. *P<0.01 compared to
group N (Student t-test).
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Figure 2. Disaccharide composition of galactosaminoglycan from normal human myometrium (N) and leiomyoma (T). A,
Concentration of unsaturated disaccharides produced by bacterial chondroitinases AC (D-glucuronic acid) and ABC (L-iduronic
acid): incubation mixtures containing 30 µg of glycosaminoglycans and 20 x 10-3 U of either Flavobacterium heparinum
chondroitinase AC or Proteus vulgaris chondroitinase ABC were prepared in 0.1 M ethylenediamine-acetate buffer, pH 7, in 30
µl final volumes. After overnight incubation at 37oC, the mixtures were applied to Whatman No. 1 filter paper and submitted
to descending chromatography in isobutyric acid: 1.25 M NH4OH, 5:3 (v/v). Reducing products were stained with alkaline
silver nitrate (17). The disaccharides that contain D-glucuronic acid were estimated by densitometry of the disaccharides
produced by the chondroitinase AC and the disaccharides that contain L-iduronic acid were estimated by the difference
between the products formed by chondroitinase ABC and AC. DDi-4S: Unsaturated 4-sulfated disaccharides; DDi-6S:
unsaturated 6-sulfated disaccharides. B, Correlation between tumor size and concentration of D-glucuronic acid-containing
(circles and squares) and L-iduronic acid-containing (lozenges) disaccharide units in galactosaminoglycans. The values are
reported as the leiomyoma/normal myometrium ratio. DDi-6S (glc): unsaturated 6-sulfated disaccharides produced from D-
glucuronic acid-containing disaccharide units; DDi-4S (glc): unsaturated 4-sulfated disaccharides produced from D-glucuronic
acid-containing disaccharide units; DDi-4S (id): unsaturated 4-sulfated disaccharides produced from L-iduronic acid-containing
disaccharide units.
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with tumor size.
It is possible that the galactosaminoglycan
chains, produced in progressively higher
amounts as the tumor grows, were not prop-
erly processed, possibly due to a lower activ-
ity of uronic acid epimerase. This possibility
was also raised by Sobue et al. (14), who
analyzed benign and malignant tumors of the
uterus, and observed that leiomyosarcomas
contain considerably larger amounts of chon-
droitin sulfate than benign tumors, which
contain dermatan sulfate with a small pro-
portion of L-iduronic acid.
Elevated matrix chondroitin sulfate has
also been correlated with the stage of pros-
tate cancer, and the measurement of chon-
droitin sulfate concentrations at diagnosis
has been proposed to allow stratification of
patients with early-stage cancer for different
therapies (20).
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